Identity
- Security key
- 21612
- Ticker
- SIGA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1997-09-09
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- SIGA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $206,208,684.92
- Shares outstanding (class)
- 71,849,716
- Shares outstanding (weighted)
- 71,849,716
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 49
- Location
- NEW YORK, NY
- Homepage
- https://www.siga.com
- Description
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.